Clinical trial
Study to Determine the Safety of PEP005 0.025% and 0.05% Topical Gel in Patients…
NCT00375739 · Peplin, Industry · Completed
Key facts
| NCT number | NCT00375739 |
|---|---|
| Title | Study to Determine the Safety of PEP005 0.025% and 0.05% Topical Gel in Patients With Actinic Keratoses |
| Official title | A Multi-center, Randomized, Double-blind, Double-dummy, Vehicle-controlled Sequential Cohort Study to Determine the Safety PEP005 0.025% and 0.05% Topical Gel in Patients With Actinic Keratoses. |
| Lead sponsor | Peplin, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Actinic Keratosis |
| Intervention type | Drug |
| Interventions | PEP005 |
| Enrollment | 200 |
| Start date | Sep 1, 2006 |
| Primary completion | Jun 1, 2007 |
| Completion | Jun 1, 2007 |
| First posted | Sep 13, 2006 |
| Last update posted | Jan 28, 2016 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: